Cécile Miles
Speciality pharmaceutical company Prosonix has announced the appointment of Cécile Miles as Chief Business Officer in order to help develop and drive Prosonix’ business development and commercial strategy.
David Hipkiss, CEO of Prosonix expressed his pleasure that Miles – who comes from being European Commercial Director at The Watson Group – was joining the company, adding:
“She will play a key role in driving Prosonix’ business development strategy over the coming years as we explore opportunities to capture the full potential value of our portfolio of directly substitutable inhaled generics and novel combination respiratory candidates.”